To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma-Reference-Cited by-同舟云学术

To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma

Published:2022-04-04 Issue:8 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Bird Nicholas¹^ORCID,Scobie Nicole²^ORCID,Palmer Antonia³^ORCID,Ludwinski Donna⁴^ORCID

Affiliation:

1. Solving Kids’ Cancer UK London United Kingdom

2. Zoé4life Sullens Switzerland

3. Kindred Foundation Oakville Ontario Canada

4. Solving Kids’ Cancer New York New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29663

Reference69 articles.

1. Clinicaltrials.gov High‐risk neuroblastoma study 2 of SIOP‐Europa‐Neuroblastoma (SIOPEN)

2. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

3. Clinicaltrials.gov Iobenguane I‐131 or crizotinib and standard therapy in treating younger patients with newly‐diagnosed high‐risk neuroblastoma or ganglioneuroblastoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review;Targeted Oncology;2024-02-24

2. Stage 4N neuroblastoma before and during the era of anti‐G_D2 immunotherapy;International Journal of Cancer;2023-08-21

3. Stem cell-conditioned medium is a promising treatment for Alzheimer's disease;Behavioural Brain Research;2023-08

4. Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2;Cancers;2023-07-22

5. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma;Pediatric Blood & Cancer;2023-07-17